Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A Prospective Study of the Incidence of Myasthenia Gravis in the East Midlands of England.

Maddison P, Ambrose PA, Sadalage G, Vincent A.

Neuroepidemiology. 2019;53(1-2):93-99. doi: 10.1159/000500268. Epub 2019 May 8.

PMID:
31067543
2.

False-positive acetylcholine receptor antibody results in patients without myasthenia gravis.

Maddison P, Sadalage G, Ambrose PA, Jacob S, Vincent A.

J Neuroimmunol. 2019 Jul 15;332:69-72. doi: 10.1016/j.jneuroim.2019.04.001. Epub 2019 Apr 3.

PMID:
30959340
3.

miR-30e-5p as predictor of generalization in ocular myasthenia gravis.

Sabre L, Maddison P, Wong SH, Sadalage G, Ambrose PA, Plant GT, Punga AR.

Ann Clin Transl Neurol. 2019 Jan 24;6(2):243-251. doi: 10.1002/acn3.692. eCollection 2019 Feb.

4.

Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis.

Sabre L, Maddison P, Sadalage G, Ambrose PA, Punga AR.

J Neuroimmunol. 2018 Aug 15;321:164-170. doi: 10.1016/j.jneuroim.2018.05.003. Epub 2018 May 8.

5.

Lambert-Eaton myasthenic syndrome and cerebellar ataxia: is Response to immunotherapy a clue to pathogenesis?

Ambrose PA, Maddison P.

Muscle Nerve. 2018 Jan 24. doi: 10.1002/mus.26079. [Epub ahead of print] No abstract available.

PMID:
29365352

Supplemental Content

Loading ...
Support Center